Key result
In patients with STEMI undergoing primary percutaneous coronary intervention, hs-CRP levels ≥ /L at admission were associated with a 19-fold higher risk of major adverse cardiovascular events compared to levels < /L.
Why the study?
Inflammation plays a key role in the pathogenesis of atherothrombosis in ST-elevation myocardial infarction, but the predictive role of high sensitivity C-reactive protein is not fully defined.
Does high sensitivity C-reactive protein predict outcomes in ST-elevation acute myocardial infarction patients undergoing primary percutaneous coronary intervention?
Cohort (n=61)
No
Does high sensitivity C-reactive protein predict outcomes in ST-elevation acute myocardial infarction patients undergoing primary percutaneous coronary intervention?
Answers are grounded in this paper and cite their sources.
Background: The role of inflammation is an important part for the process of acute myocardial infarction. Inflammation of blood vessel walls and inflammatory response are considered as the main pathogenesis of atherothrombosis in ST elevation of myocardia
No takes yet. Share an insight, caveat, or question.
SURYAWAN et al. (2023) conducted a cohort in ST-Elevation Acute Myocardial Infarction (STEMI) (n=61). High sensitivity C-Reactive Protein (hs-CRP) ≥ 2 mg/L vs. hs-CRP < 2 mg/L was evaluated on Major Adverse Cardiovascular Event (MACE) (OR 19.158, p=0.006). In patients with STEMI undergoing primary percutaneous coronary intervention, hs-CRP levels ≥ /L at admission were associated with a 19-fold higher risk of major adverse cardiovascular events compared to levels < /L.
Synapse has enriched 10 related papers. Consider them for comparative context: